Healthcare provider profile · identity verified

Howard Jay Miller, M.D.

Internal Medicine · COUDERSPORT, PA · NPI 1720197726

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Potassium Chloride	Potassium Chloride	386	35
Pantoprazole Sodium	Pantoprazole Sodium	361	31
Gabapentin	Gabapentin	345	19
Furosemide	Furosemide	343	27
Levothyroxine Sodium	Levothyroxine Sodium	322	29
Quetiapine Fumarate	Quetiapine Fumarate	293	18
Omeprazole	Omeprazole	281	20
Metformin Hcl	Metformin Hcl	273	17
Atorvastatin Calcium	Atorvastatin Calcium	269	31
Tamsulosin Hcl	Tamsulosin Hcl	268	20
Eliquis	Apixaban	264	23
Amlodipine Besylate	Amlodipine Besylate	250	18
Metoprolol Succinate	Metoprolol Succinate	226	22
Trazodone Hcl	Trazodone Hcl	209	12
Losartan Potassium	Losartan Potassium	208	16
Famotidine	Famotidine	206	15
Lisinopril	Lisinopril	186	20
Mirtazapine	Mirtazapine	182	18
Memantine Hcl	Memantine Hcl	178	11
Escitalopram Oxalate	Escitalopram Oxalate	171	11
Warfarin Sodium	Warfarin Sodium	166	suppressed
Lorazepam	Lorazepam	164	17
Metoprolol Tartrate	Metoprolol Tartrate	160	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	144	17
Simvastatin	Simvastatin	141	suppressed
Tramadol Hcl	Tramadol Hcl	138	14
Carbidopa-Levodopa	Carbidopa/Levodopa	125	suppressed
Spironolactone	Spironolactone	124	12
Donepezil Hcl	Donepezil Hcl	121	suppressed
Citalopram Hbr	Citalopram Hydrobromide	112	11
Duloxetine Hcl	Duloxetine Hcl	109	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	104	13
Venlafaxine Hcl Er	Venlafaxine Hcl	104	suppressed
Ceftriaxone	Ceftriaxone Sodium	90	33
Xarelto	Rivaroxaban	90	suppressed
Divalproex Sodium	Divalproex Sodium	89	suppressed
Carvedilol	Carvedilol	88	13
Doxycycline Hyclate	Doxycycline Hyclate	85	14
Prednisone	Prednisone	84	suppressed
Allopurinol	Allopurinol	82	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	73	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	73	suppressed
Haloperidol	Haloperidol	67	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	67	suppressed
Azithromycin	Azithromycin	65	22
Benztropine Mesylate	Benztropine Mesylate	65	suppressed
Sertraline Hcl	Sertraline Hcl	65	suppressed
Lidocaine Hcl	Lidocaine Hcl	64	30
Baclofen	Baclofen	61	suppressed
Ropinirole Hcl	Ropinirole Hcl	60	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	59	26
Jardiance	Empagliflozin	59	suppressed
Olanzapine	Olanzapine	59	suppressed
Topiramate	Topiramate	59	suppressed
Morphine Sulfate Er	Morphine Sulfate	57	suppressed
Buspirone Hcl	Buspirone Hcl	56	suppressed
Glipizide Er	Glipizide	56	suppressed
Pravastatin Sodium	Pravastatin Sodium	55	suppressed
Amiodarone Hcl	Amiodarone Hcl	53	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	52	15
Levetiracetam	Levetiracetam	52	suppressed
Rivastigmine	Rivastigmine	52	suppressed
Albuterol Sulfate	Albuterol Sulfate	51	13
Lamotrigine	Lamotrigine	51	suppressed
Cephalexin	Cephalexin	50	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	50	suppressed
Acyclovir	Acyclovir	49	suppressed
Creon	Lipase/Protease/Amylase	48	suppressed
Lactulose	Lactulose	48	suppressed
Finasteride	Finasteride	47	suppressed
Myrbetriq	Mirabegron	47	suppressed
Clonazepam	Clonazepam	46	suppressed
Digoxin	Digoxin	46	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	46	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Primidone	Primidone	43	suppressed
Sodium Chloride	0.9 % Sodium Chloride	43	13
Lovastatin	Lovastatin	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	suppressed
Repaglinide	Repaglinide	41	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	41	16
Cilostazol	Cilostazol	40	suppressed
Fluconazole	Fluconazole	40	suppressed
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	35	suppressed
Cholestyramine	Cholestyramine (With Sugar)	35	suppressed
Morphine Sulfate	Morphine Sulfate	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Calcitriol	Calcitriol	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Amantadine	Amantadine Hcl	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Methenamine Hippurate	Methenamine Hippurate	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Budesonide	Budesonide	28	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Febuxostat	Febuxostat	27	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	27	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Ramipril	Ramipril	26	suppressed
Amoxicillin	Amoxicillin	25	suppressed
Niacin Er	Niacin	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	25	suppressed
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Ertapenem	Ertapenem Sodium	24	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Nyamyc	Nystatin	21	12
Prazosin Hcl	Prazosin Hcl	20	suppressed
Verapamil Hcl	Verapamil Hcl	20	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Folic Acid	Folic Acid	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Methimazole	Methimazole	18	suppressed
Carbamazepine Er	Carbamazepine	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Theophylline Er	Theophylline Anhydrous	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Risperidone	Risperidone	14	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Silodosin	Silodosin	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Colchicine	Colchicine	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Emgality Pen	Galcanezumab-Gnlm	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Valsartan	Valsartan	12	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	11	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error